Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid

Transplantation

Volumn 90, Issue 3, 2010, Pages 306-311

  Pasqualotto, Alessandro C ^a,b,c   Xavier, Melissa O ^a   Sánchez, Letícia B ^d   De Oliveira Costa, Clarice D A ^d   Schio, Sadi M ^d   Camargo, Spencer M ^d   Camargo, Jose J ^d   Sukiennik, Teresa C T ^b   Severo, Luiz Carlos ^a,c,e  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Infection Control Department   (Brazil)

^c Brazilian Government ^*  (Brazil)

^d Santa Casa de Porto Alegre   (Brazil)

^e Mycology Laboratory   (Brazil)

Author keywords

Aspergillus; Bronchoalveolar lavage fluid; Diagnosis; Galactomannan; Lung transplantation

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AZATHIOPRINE; CYCLOSPORIN; GALACTOMANNAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CAUSE OF DEATH; CHILD; FALSE POSITIVE RESULT; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERMETHOD COMPARISON; INVASIVE ASPERGILLOSIS; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CHI-SQUARE DISTRIBUTION; CHILD; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INVASIVE PULMONARY ASPERGILLOSIS; LUNG TRANSPLANTATION; MALE; MANNANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955415296     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e49bc1     Document Type: Article

References (23)

1. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbio Rev 2005; 18: 44.
2. Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine 1999; 78: 123.
3. Silveira FP, Husain S. Invasive pulmonary aspergillosis in solid organ transplant recipients. In: Pasqualotto AC, ed. Aspergillosis: From Diagnosis to Prevention. Springer Science+Business Media 2010, pp 567. London, New York; Springer Dordrecht Heidelberg; 2010.
4. Mehrad B, Paciocco G, Martinez FJ, et al. Spectrum of Aspergillus infection in lung transplant recipients: Case series and review of the literature. Chest 2001; 119: 169.
5. DePauwB, Walsh TJ, Donnelly JP,etal. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813.
6. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-analysis. Clin Infect Dis 2006; 42: 1417.
7. Clancy CJ, Jaber RA, Leather HL, et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 2007; 45: 1759.
8. Husain S, Clancy CJ, Nguyen MH, et al. Performance characteristics of the Platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin Vaccine Immunol 2008; 15: 1760.
9. Husain S, Paterson DL, Studer SM, et al. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 2007; 83: 1330.
10. Hope WW, Kruhlak MJ, Lyman CA, et al. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: Implications for antifungal therapy. J Infect Dis 2007; 195: 455.
11. Penack O, Rempf P, Graf B, et al. Aspergillus galactomannan testing in patients with long-term neutropenia: Implications for clinical management. Ann Oncol 2008; 19: 984.
12. Humar A, Michaels M. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006; 6: 262.
13. Iversen M, Burton CM, Vand S, et al. Aspergillus infection in lung transplant patients: Incidence and prognosis. Eur J Clin Microbiol Infect Dis 2007; 26: 879.
14. Sole A, Morant P, Salavert M, et al. Aspergillus infections in lung transplant recipients: Risk factors and outcome. Clin Microbiol Infect 2005; 11: 359.
15. Minari A, Husni R, Avery RK, et al. The incidence of invasive aspergil-losis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis 2002; 4: 195.
16. TM Aspergillus galactomannan antigen for the diagnosis of invasive aspergillo-sis in lung transplant recipients. Am J Transpl 2004; 4: 796.
17. Westney GE, Kesten S, De Hoyos A, et al. Aspergillus infection in single and double lung transplant recipients. Transplantation 1996; 61: 915.
18. Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998; 26: 753.
19. Cahill BC, Hibbs JR, Savik K, et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997; 112: 1160.
20. Arthurs SK, Eid AJ, Deziel PJ, et al. The impact of invasive fungal diseases on survival after lung transplantation. Clin Transplant (in press).
21. Maertens J, Maertens V, Theunissen K, et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergil-losis in patients with hematologic diseases. Clin Infect Dis 2009; 49: 1688.
22. Ding Y, Phua J, Koh L, et al. Bronchoalveolar lavage galactomannan testing in the diagnosis of invasive pulmonary aspergillosis [abstract K-947]. Presented at 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, 2009.
23. Nguyen MH, Jaber R, Leather HL, et al. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmuno-compromised hosts. J Clin Microbiol 2007; 45: 2787.